HCA Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCA Healthcare (HCA).

Price Target Range — 9 Quarters

Analyst Consensus — 22 Analysts

15Buy

6Hold

1Sell

Consensus RatingBuy# Analysts22Avg. Consensus PT$476Upside to Avg. PT+6.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$435→$496
Sep 23, 2026	BMO Capital	Sean Dodge	Initiate	Outperform	$495
Sep 18, 2026	Leerink Partners	Whit Mayo	Maintained	Outperform	$492
Sep 8, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Aug 20, 2026	JP Morgan	Benjamin Rossi	PT Cut	Neutral	$490→$425
Aug 3, 2026	Wells Fargo	Stephen Baxter	PT Raise	Equal-Weight	$369→$381
Jul 28, 2026	Goldman Sachs	Scott Fidel	PT Cut	Buy	$558→$485
Jul 28, 2026	Mizuho	Ann Hynes	PT Cut	Outperform	$525→$475
Jul 27, 2026	UBS	A.J. Rice	PT Cut	Buy	$635→$579
Jul 27, 2026	Morgan Stanley	Craig Hettenbach	PT Cut	Underweight	$425→$380
Jul 27, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Jul 27, 2026	Truist Securities	David Macdonald	PT Cut	Buy	$535→$495
Jul 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$520→$485
Jul 27, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$475→$435
Jul 27, 2026	Baird	Michael Ha	PT Cut	Neutral	$396→$393
Jul 27, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$402→$387
Jul 16, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$427→$402
Jul 15, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$534→$435
Jul 14, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$510→$475
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Cut	Equal-Weight	$436→$428

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.

Benzinga Newsdesk

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.

Avi Kapoor

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $369 to $381.

Benzinga Newsdesk

HCA Healthcare Inc

HCA Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

People Also Watch

People Also Watch

HCA Healthcare Inc

HCA Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROBMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRORBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PROJP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PROWells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

People Also Watch

People Also Watch

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381